Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in mice
- PMID: 20484223
- DOI: 10.1093/hmg/ddq207
Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in mice
Abstract
Mutations of the PALB2 tumor suppressor gene in humans are associated with hereditary predisposition to breast and also some other cancers. In the present study, we have characterized mice deficient in Palb2. The data show that the Palb2((+/-)) mice are normal and fertile, and lack macroscopic tumors when followed up till the age of 8 months. Homozygous (HO) Palb2((-/-)) mice present with embryonic lethality and die at E9.5 at the latest. The mutant embryos are smaller in size, developmentally retarded and display defective mesoderm differentiation after gastrulation. In Palb2((-/-)) embryos, the expression of cyclin-dependent kinase inhibitor p21 is increased, and Palb2((-/-)) blastocysts show a growth defect in vitro. Hence, the phenotype of the Palb2((-/-)) mice in many regards resembles those previously reported for Brca1 and Brca2 knockout mice. The similarity in the phenotypes between Palb2, Brca1 and Brca2 knockout mice further supports the functional relationship shown in vitro for these three proteins. Accordingly, our data in vivo suggest that a key function for PALB2 is to interact with and to build up appropriate communication between BRCA1 and BRCA2, thereby licensing the successful performance of the physiological tasks mediated by these two proteins, particularly in homologous recombination and in proper DNA damage response signaling.
Similar articles
-
Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression.J Pathol. 2011 May;224(1):10-21. doi: 10.1002/path.2861. Epub 2011 Mar 14. J Pathol. 2011. PMID: 21404276
-
Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation.Nat Genet. 1997 Jul;16(3):298-302. doi: 10.1038/ng0797-298. Nat Genet. 1997. PMID: 9207798
-
Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.Breast Cancer Res Treat. 2009 Feb;113(3):545-51. doi: 10.1007/s10549-008-9945-0. Epub 2008 Feb 27. Breast Cancer Res Treat. 2009. PMID: 18302019
-
Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.Cancer Res. 2008 Feb 15;68(4):998-1002. doi: 10.1158/0008-5472.CAN-07-2418. Cancer Res. 2008. PMID: 18281473
-
A recurrent mutation in PALB2 in Finnish cancer families.Nature. 2007 Mar 15;446(7133):316-9. doi: 10.1038/nature05609. Epub 2007 Feb 7. Nature. 2007. PMID: 17287723
Cited by
-
Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer.Cancer Discov. 2013 Aug;3(8):894-907. doi: 10.1158/2159-8290.CD-13-0011. Epub 2013 May 6. Cancer Discov. 2013. PMID: 23650262 Free PMC article.
-
PALB2 (partner and localizer of BRCA2).Atlas Genet Cytogenet Oncol Haematol. 2018 Apr;22(12):484-490. doi: 10.4267/2042/69016. Atlas Genet Cytogenet Oncol Haematol. 2018. PMID: 31413733 Free PMC article.
-
Loss of the BRCA1-PALB2 interaction accelerates p53-associated tumor development in mice.Genes Dis. 2020 Sep 5;9(3):807-813. doi: 10.1016/j.gendis.2020.08.012. eCollection 2022 May. Genes Dis. 2020. PMID: 35782971 Free PMC article.
-
Fanconi anemia signaling and Mus81 cooperate to safeguard development and crosslink repair.Nucleic Acids Res. 2014 Sep;42(15):9807-20. doi: 10.1093/nar/gku676. Epub 2014 Jul 23. Nucleic Acids Res. 2014. PMID: 25056314 Free PMC article.
-
Concise Review: Getting to the Core of Inherited Bone Marrow Failures.Stem Cells. 2017 Feb;35(2):284-298. doi: 10.1002/stem.2543. Epub 2016 Dec 4. Stem Cells. 2017. PMID: 27870251 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous